ENGMAB ENGINEERING FOR BETTER THERAPIES Trademark

Trademark Overview


On Monday, December 2, 2013, a trademark application was filed for ENGMAB ENGINEERING FOR BETTER THERAPIES with the United States Patent and Trademark Office. The USPTO has given the ENGMAB ENGINEERING FOR BETTER THERAPIES trademark a serial number of 79142423. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Friday, December 1, 2023. This trademark is owned by EngMab AG. The ENGMAB ENGINEERING FOR BETTER THERAPIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products; therapeutic drugs and agents, namely antibody-based therapies, antibodies, antibody fragments, bispecific antibodies, T-cell bispecific antibodies; pharmaceutical preparations namely antibody engineering, antibody production and purification, for the treatment of hematological malignancies, solid tumors and diseases of the immune system, namely multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphomas, systemic lupus erythematosus
engmab engineering for better therapies

General Information


Serial Number79142423
Word MarkENGMAB ENGINEERING FOR BETTER THERAPIES
Filing DateMonday, December 2, 2013
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateFriday, December 1, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the lettering "ENGMAB" where "E" and "M" appear in blue and the remaining letters in black; two stylized yellow chevrons separate the letter from the wording "ENGINEERING FOR BETTER THERAPIES" in blue.
Goods and ServicesPharmaceutical products; therapeutic drugs and agents, namely antibody-based therapies, antibodies, antibody fragments, bispecific antibodies, T-cell bispecific antibodies; pharmaceutical preparations namely antibody engineering, antibody production and purification, for the treatment of hematological malignancies, solid tumors and diseases of the immune system, namely multiple myeloma, chronic lymphocytic leukemia, acute myeloid leukemia, non-Hodgkin lymphomas, systemic lupus erythematosus
Pseudo MarkENG MAB ENGINEERING FOR BETTER THERAPIES
Indication of Colors claimedThe color(s) blue, black and yellow is/are claimed as a feature of the mark.
NOT AVAILABLE"ENGINEERING"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, December 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEngMab AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH

Trademark Events


Event DateEvent Description
Monday, February 17, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 18, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 22, 2014APPLICATION FILING RECEIPT MAILED
Friday, March 14, 2014ASSIGNED TO EXAMINER
Wednesday, March 19, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, March 19, 2014REFUSAL PROCESSED BY MPU
Wednesday, March 19, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 4, 2014REFUSAL PROCESSED BY IB
Friday, May 30, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2014FINAL REFUSAL WRITTEN
Tuesday, August 12, 2014FINAL REFUSAL MAILED
Wednesday, January 14, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 14, 2015TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, January 28, 2015ASSIGNED TO LIE
Wednesday, February 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, March 22, 2015ABANDONMENT - INCOMPLETE RESPONSE
Monday, March 23, 2015ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Wednesday, July 15, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 15, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 22, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 5, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 18, 2014NON-FINAL ACTION WRITTEN
Friday, May 30, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 30, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 31, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, March 22, 2016FINAL DISPOSITION NOTICE SENT TO IB
Sunday, June 30, 2024DEATH OF INTERNATIONAL REGISTRATION
Sunday, June 30, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED